Capital B H1 Financials: Bitcoin Impairment Drives €69.5M Net Loss

On October 16th, French-listed Bitcoin investment firm Capital B released its financial results for the first half of 2026. The report indicates the company generated revenue of €5.846 million, a modest 3.5% increase compared to the same period last year. However, its bottom line told a different story.

The Primary Driver: Non-Cash Bitcoin Impairment

The most striking figure in the report is a net loss of approximately €69.5 million, a significant expansion from the €1.86 million loss reported a year ago. The company clarified that the primary cause of the loss was not operational expenses, but rather an impairment charge of roughly €67.5 million, booked due to the decline in Bitcoin's market price as of June 30th.

Critically, this substantial impairment is an accounting adjustment under relevant standards and does not represent an actual outflow of cash. This means the company's cash flow position was not directly impacted, although the asset value and shareholders' equity on its balance sheet were reduced accordingly.

Bitcoin Strategic Reserve Continues to Grow

Despite the paper loss stemming from market volatility, Capital B's long-term Bitcoin strategy appears unwavering. The report revealed that as of September 30th, the company's strategic Bitcoin reserve had increased to 3,538 coins, marking a 25.3% growth from the beginning of the year.

  • Cumulative Acquisition Cost: ~€310.6 million
  • Average Cost per Coin: ~€87,805
  • Reserve Growth: Up 25.3% since year-start

This suggests the company continues to execute its stated Bitcoin accumulation strategy amidst market price fluctuations. The gap between the current market price of Bitcoin and the company's average cost will directly influence whether future financial reports show impairment reversals or further write-downs.

This half-year report underscores the significant impact crypto asset market volatility can have on the financial statements of companies holding substantial digital assets. Investors evaluating such firms must carefully distinguish between non-cash impairment losses and the actual operational cash flow and underlying business health.